Loading
Dan O'Connor

Dan O'Connor

Director, Regulatory Policy & Early Access , ABPI

Dan O'Connor is UK medically (Leicester) and PhD (Imperial) qualified and currently the Director Regulatory and Early Access Policy at The Association of the British Pharmaceutical Industry (ABPI). He joined the ABPI from the Medicines and Healthcare products Regulatory Agency in 2023 where he was Deputy Director of the Innovation Accelerator and Regulatory Science. Dan has special interests in drug development, rare diseases, regulatory science, early access, health innovation, patient engagement and drug repurposing. He completed higher medical training in Pharmaceutical Medicine and is Editor-Author of the Oxford Specialist Handbook in Pharmaceutical Medicine. He is a co-leading the work of the UK Rare Therapies Launch Pad (The Rare Therapies Launchpad: a pilot program for individualized medicines in the UK | Nature Medicine) 

Sessions